Stocksigma LogoStocksigma Logo

Dr. Lal PathLabs Board to Consider Q2 Results and Second Interim Dividend

Dr. Lal PathLabs Limited announced that its Board of Directors will meet on 4th Nov'26 to consider and approve the un-audited standalone and consolidated

Dr. Lal PathLabs Board to Consider Q2 Results and Second Interim Dividend

Dr. Lal PathLabs Ltd 路 Dividend 路 27 Oct 2026, 10:09 pm

Dr. Lal PathLabs Board to Consider Q2 Results and Second Interim Dividend Dr. Lal PathLabs Limited announced that its Board of Directors will meet on 4th Nov'26 to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the Board will consider the declaration of a 2nd Interim Dividend on equity shares for FY27 during the same meeting.

Original exchange filing (PDF)

More announcements from Dr. Lal PathLabs Ltd

  • Attached 路 11 Nov 2026
  • Attached 路 10 Nov 2026
  • Attached 路 05 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. 路 04 Nov 2026
  • Attached 路 04 Nov 2026

All Dr. Lal PathLabs Ltd announcements